RxDoctor Payments Data

Juan Hernandez, MD

Family Medicine · Dixon, ILNPI 1780650176

Payments from drug & device makers

$2,247in general payments, 2019–2025

Across 145 payments — averaging $15.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$511
  • AstraZeneca$396
  • Pfizer$241
  • E.r. Squibb & Sons, L.L.C.$140
  • Amgen$139
  • Lilly USA, LLC$128
  • plus $691 from 12 others

What the payments were for

  • Food & beverage$2,241100%
  • Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,247 in reported general payments places this provider in the 80th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$100,962
Medicare patients
357
Services billed
1,885

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide206$230,387
EliquisApixaban185$212,332
FarxigaDapagliflozin Propanediol64$70,572
JardianceEmpagliflozin46$55,606
MounjaroTirzepatide38$47,855
Trelegy ElliptaFluticasone/Umeclidin/Vilanter64$40,723
RybelsusSemaglutide25$32,377
Tresiba Flextouch U-200Insulin Degludec43$31,164
Breo ElliptaFluticasone/Vilanterol57$29,108
JanuviaSitagliptin Phosphate25$26,547
TrulicityDulaglutide24$25,379
KerendiaFinerenone20$14,270
Breztri AerosphereBudesonide/Glycopyr/Formoterol19$11,503
SymbicortBudesonide/Formoterol Fumarate17$10,411
MyrbetriqMirabegron13$10,394

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$511$262,763231 claims
PfizerEliquis, Paxlovid$241$213,819207 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$396$92,486100 claims
Lilly USA, LLCMounjaro, Trulicity$128$73,23462 claims
GSKTrelegy Ellipta, Breo Ellipta$58$69,831121 claims
Boehringer IngelheimJardiance$85$55,60646 claims
MerckJanuvia$70$26,54725 claims
BayerKerendia$119$14,27020 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Dixon

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →